Defining the structural and antigenic properties of EBA-175 RIII-V — ASN Events
  1. Schedule
  2. Session 10: Poster Session C
  3. Defining the structural and antigenic properties of EBA-175 RIII-V

Defining the structural and antigenic properties of EBA-175 RIII-V (#327)

Andrew J Guy 1 2 , James G Beeson 1 3 , Christine Langer 1 , Paul Sanders 1 , Peter Siba 4 , Ivo Mueller 4 5 , Matthew Stellato 6 , Marie-Isabel Aguilar 6 , Jack S Richards 1 3 , Paul A Ramsland 1 2
  1. Centre for Biomedical Research, Burnet Institute, Melbourne, VIC, Australia
  2. Department of Immunology, Monash University, Melbourne, VIC, Australia
  3. Department of Microbiology, Monash University, Melbourne, VIC, Australia
  4. Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea
  5. Infection and Immunity Division, Walter and Eliza Hall Institute, Melbourne, VIC, Australia
  6. Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC, Australia
Publish consent withheld
  1. Richards, J.S., et al., Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemia. Clinical Infectious Diseases, 2010. 51(8): p. e50-60
  2. Healer, J., et al., Vaccination with Conserved Regions of Erythrocyte-Binding Antigens Induces Neutralizing Antibodies against Multiple Strains of Plasmodium falciparum. PLoS ONE [Electronic Resource], 2013. 8(9): p. e72504.
  3. Sim, B.K., et al., Primary structure of the 175K Plasmodium falciparum erythrocyte binding antigen and identification of a peptide which elicits antibodies that inhibit malaria merozoite invasion. Journal of Cell Biology, 1990. 111(5 Pt 1): p. 1877-84.